| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2018 | Cellular 5-hydroxylmethylcytosine content determines tumorigenic potential and prognosis of pancreatic ductal adenocarcinoma | Chen, YL; Hu, CM; Hsu, JT; Chang, CC; Huang, TY; Chiang, PH; Chen, WY; Chang, YT; Chang, MC; Tien, YW; Lee, EY; Jeng, YM; Lee, WH | American journal of cancer research 8(12), 2548-2563 | | | |
| 2021 | Characterization of Initial Key Steps of IL-17 Receptor B Oncogenic Signaling for Targeted Therapy of Pancreatic Cancer | Wu, HH; Tsai, LH; Huang, CK; Hsu, PH; Chen, MY; Chen, YI; Hu, CM ; Shen, CN ; Lee, CC; Chang, MC; Chang, YT; Tien, YW; Jeng, YM; Lee, EYP; Lee, WH | Science Translational Medicine 13(583), eabc2823 | | | |
| 2016 | Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma. | Chang, MC; Chang, YT; Chen, JY; Jeng, YM; Yang, CY; Tien, YW; Yang, SH; Chen, HL; Liang, TY; Wang, CF; Lee, EY; Chang, YC; Lee, WH | Clinical chemistry 62(3), 505-13 | | | |
| 2012 | Crystal structure of Staphylococcus aureus transglycosylase in complex with a lipid II analog and elucidation of peptidoglycan synthesis mechanism. | Huang, CY; Shih, HW; Lin, LY; Tien, YW; Cheng, TJ; Cheng, WC; Wong, CH; Ma, C | Proceedings of the National Academy of Sciences of the United States of America 109(17), 6496-6501 | | | |
| 2019 | Inducing a Transient Increase in Blood–Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme | Lundy, DJ; Lee, KJ; Peng, IC; Hsu, CH; Lin, JH; Chen, KH; Tien, YW; Hsieh, PC | ACS Nano 13(1), 97-113 | | | |
| 2016 | Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2. | Chang, EY; Chang, YC; Shun, CT; Tien, YW; Tsai, SH; Hee, SW; Chen, IJ; Chuang, LM | PloS one 11(1), e0147390 | | | |
| 2019 | Lymphatic vessel remodeling and invasion in pancreatic cancer progression. | Shen, CN ; Goh, KS; Huang, CR; Chiang, TC; Lee, CY; Jeng, YM; Peng, SJ; Chien, HJ; Chung, MH; Chou, YH; Hsieh, CC; Kulkarni, S; Pasricha, PJ; Tien, YW; Tang, SC | EBioMedicine 47, 98-113 | | | |
| 2015 | Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines | Wu, HH; Hwang-Verslues, WW; Lee, WH; Huang, CK; Wei, PC; Chen, CL; Shew, JY; Lee, EY; Jeng, YM; Tien, YW; Ma, C; Lee, WH | Journal of Experimental Medicine 212(3), 333-349 | | | |
